The health ministry's latest guidelines for Covid-19 treatment advise against several drugs that were being used widely until recently. Two experts tell us how these guidelines should be updated more efficiently, as well as questioned and reviewed frequently.

Govindraj Ethiraj

    Govindraj Ethiraj is a television and print journalist who has reported and written on Indian business for over 25 years. He is a media executive and entrepreneur whose public interest journalism ventures including IndiaSpend, FactChecker and BOOM, are safeguarding the transparency, accuracy, and integrity of news in specific and the internet in general in India and world-wide. Previously, he was Founder-Editor in Chief of Bloomberg TV India, Editor (New Media) with Business Standard newspaper, and in various capacities at CNBC-TV18, The Economic Times and leading business magazine. He continues to anchor seasonal shows in the business, economy and financial markets space, on Indian broadcast television and on digital. Govindraj was named a 2018 McNulty Prize Laureate in recognition for his leadership with BOOM, IndiaSpend, and FactChecker. He is a Fellow of the Inaugural Class of Ananta Aspen’s India Leadership Initiative and the Aspen Global Leadership Network, and winner of the 2014 BMW Responsible Leaders Awards.